culosis
(Robert Fleischmann, TIGR; Bart Barrell, Sanger Centre, Hinxton, UK) and Archaeoglobus fulgidus (Hans-Peter Klenk, TIGR), to name but a few [see Table 1 for an approximation of current genome projects as gleaned from this meeting and various URLs (see Table 2 )].
What follows is a necessarily superficial account of the extraordinary volume and diversity of information presented at this meeting. No doubt, during the coming year these data will appear in the public domain at an exhausting rate.
What use are genome sequences?
One example presented at this ground-breaking meeting did elegantly demonstrate the power that knowledge of a whole genome can bring to understanding a biological problem. For several years, Richard Moxon and colleagues (University Small Genomes: Sequencing, Functional Characterization and Comparative Genomics (TIGR Science Education Foundation conference) held at Hilton Head, SC, USA, 25-28 January 1997.
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e-mail: c.asb@elsevier.co..k of Oxford, UK) have been exploring the genetics of phase variation in Haemophilus influenzae, the first organism to have its genome completely sequenced 1. All aspects of the pathogenicity of this microorganism are governed by the properties of its lipopolysaccharide (LPS). The basis for antigenic variation in H. influenzae lies in frameshifting among tetrameric repeats that regulate expression of glycosyltransferase and, hence, the biosynthesis of the terminal O antigen region of the LPS molecule. By having access to the whole genome sequence, Moxon's group have exponentially increased their rate of progress and, by probing for known LPS biosynthetic sequences in other organisms, have identified 25 genes scattered around the chromosome. They can now make series of mutants and test their virulence in their infant rat model. Thus, they can map the minireal LPS structural requirements for survival in specific tissues.
How to sequence small genomes
The landmark announcement of the meeting was of the submission of the complete genome sequence of E. coil on 16 January 1997 by Fred Blattner and colleagues and the Japan E. coli Genome Sequence Group (Hirotada Mori, Nara Institute of Science, Japan) 2. This project has taken 5 years to sequence ~5 million bases by mapping of restriction fragments and overlapping )v clones.
Shotgun sequencing undoubtedly allows for much faster progress but is reliant on massive computer support. Another essential prerequisite is the preparation of reliably random libraries, something that Ham Smith's team at Johns Hopkins University School of Medicine (Baltimore, MD, USA) excel at. Although ordered cosmid libraries will still be used, for example in the M. tuberculosis project, shotgunning is becoming widely adopted and will be used in the Plasmodium falciparum genome project (Steve Hoffman, Naval Medical Research Institute, Rockville, MD, USA). Consequently, obtaining 90% of the sequence of a small genome is becoming routine; the other half of the task is to close the gaps between the contigs. This is the point that the T. pallidurn project (Claire Fraser) has reached.
By now, the T. pallidum sequence has probably been closed, and Fraser is pursuing annotation. The next major challenge is to extract meaningful information from the sequence. Already, interesting pointers have come from comparing T. pallidum with Mycoplasma genitalium. These obligate pathogens show similarities in their parsimonious selection of genes for metabolism, but it is not immediately apparent why M. genitaliurn can grow in vitro and T. pallidum cannot. A high proportion of the T.
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pallidurn genome is devoted to the cell envelope and flagellar genes and, interestingly, generally lacks repetitive elements, except for 15 copies of a major outer sheath protein, which is possibly a porin, analogous to the major outer sheath protein of Treponema denticola;
Fraser aims to resequence this section to verify its functional characteristics. Fraser is also managing the sequencing of another spirochaete, B. burgdorferi, a project that should greatly benefit from the T. pallidurn sequence. An interesting, but complicating, characteristic of Borrelia is the presence of several linear and circular plasmids comprising up to 30% of its bulk DNA. However, these are shed rapidly when the organism is cultured, causing the organism to lose its ability to infect animals, suggesting that the plasmids contain key virulence genes.
Assigning function
Since the completion of the yeast genome project, the impetus of the consortium has refocussed on functional analysis (Bernard Dujon Rickettsia prowazekii is also an obligate intracellular pathogen with a small (1.1Mb) and plastic genome that shares some relationship with the mammalian mitochondrial genome. R. prowazekii has few amino acid biosynthetic pathways but, unlike M. genitalium, which relies on glycolysis alone, R. prowazekii only requires a tricarboxylic acid cycle to generate energy (Siv Andersson, Uppsala, Sweden). The main genetic problem for this organism is that it has a semi-clonal population structure. Andersson has been monitoring strain variation in S-adenosylmethionine synthetase, an essential enzyme for polyamine metabolism. It suffers a very high rate of deletion and susbstitution with a tenfold greater fixation rate than the corresponding enzyme of E. cob; a feature that Andersson expects to be common for intracellularly replicating parasites. The end result for any particular clone is mutational meltdown. This organism fulfils Maynard-Smith's maxim that life without sex is an evolutionary scandal.
Wild genomes
Although the majority of small genomes that have been, or are being, sequenced are of pathogens, there is certainly an enthusiastic gold rush feeling about exploring genomes obtained from other environments. Regardless of the potential for novel industrial products, Norman Pace (University of California, Berkeley, USA) is fervent in his exploration for uncultivatable organisms that represent the spectacular majority of biodiversity. Pace uses conserved rRNA-based PCR primers to derive 'phylotypes' of organisms. His protege, Ed deLong (University of California, Santa Barbara, USA) has taken on the challenge by monitoring seasonal distributions of uncultivatable archaeans in oceanic waters. Another way of sampling the environment for potentially exploitable microorganisms is simply to screen for gene products with no reference to the originating genomes. Eric Mathur (Recombinant BioCatalysis Inc., La Jolla, CA, USA) outlined their strategy for the discovery of industrial enzymes from uncultivatable organisms; they use a combination of phylogenetic trees as 'road maps' and recombinant protein screening from 'environmental libraries' obtained from DNA extracted directly from samples. His company is sampling the extremes, from insect guts to whale carcasses (which contain microorganisms with interesting esterases), as well as the, by now obligatory, survey of hydrothermal vent flora; the only bottleneck to their environmentwide surveying is the limitations of their robotic screening capacity. They are looking for enzymes with specific properties, such as thermal tolerance, long shelf life and resistance to solvents, and so far have recovered 300 industrially relevant enzymes.
Conclusions
There is still a sense of gaining immense power from genomics but having little to fire it at, as knowledge of an entire genome will not automatically answer a lot of questions about an organism's biology. Of course, it will tell us general features (Robert Fleischmann) about small genome organization, pinpoint many of the open reading frames and open the door to the discovery of genes for virulence, drug and vaccine targets, diagnostic tests and industrially important enzymes, among many other properties. What remains a limitation is a lack of agreement about gene nomenclature and the huge potential for confusion and misattribution of function (Craig Venter). But the main thing that knowledge of the genome does reveal is how little we do actually know and the potentially astonishing complexity and plasticity of even the smallest genomes. It also demonstrates the quite extraordinary ingenuity and collaborative powers of the disparate group of technologists who work on genome sequencing.
The next meeting, Small Genomes II, will also be held at Hilton Head Island from 31 January to 4 February 1998. See genome@ t, igr. org for details.
Letters

A paradigm for virus-induced demyelinating disease
Paradigm: an outstandingly clear and typical example. Longmans Dictionary I n their recent review in Trends in Microbiology I, Lane and Buchmeier present murine infection with the mouse hepatitis coronavirus (MHV) as a paradigm for virus-induced demyelinating disease in humans, in particular for multiple sclerosis (MS). Such a paradigm would presumably also be valid for the known human virus-induced demyelinating diseases such as postmeasles encephalomyelitis, progressive multifocal leukoencephalopathy (papovavirus) or tropical spastic paraparesis (human T cell leukaemia virus type 1).
The etiology of the multifactorial disease MS is still unknown, but MS remains a prime candidate for a virus-induced demyelinating disease-', and an adequate animal model would certainly be a great benefit to MS research. A series of inbred murine (or rodent) models for MS exist: an antigen-based experimental allergic encephalomyelitis (EAE) and several virus-mediated modem including coronavirus, lactic dehydrogenase/N-tropic C-type virus ~ and Theiler's encephalomyelitis virus 4. All these models suffer from two major drawbacks: they do not represent the highly variable manifestations of MS (from subclinical course over relapsing and remitting forms to slow or fast chronic progressing disease) and they are all rodent-based. The basic structure of the immune system in rodents and humans is very similar and, therefore, it is tempting to assume that an immunoregulatory mechanism found in one is automatically present in the other. This is indeed the case in some instances, but not always: a costly lesson that was learned in MS therapy% It seems reasonable to caution against presentations like Table 1 in the review by Lane and Buchmeier. An MS exacerbation does not necessarily correspond to an MHV-induced exacerbation in mice, and the implications of a cytokine response differ in the two cases. We still do not have a paradigm for human virus-induced demyelinating diseases/MS, and mice are not men.
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